Katriina Vuolteenaho

Activities

Activities per year 1999 2009 2010 2011 2012 2013 2016 2017 2018 2023

• 156 Conference presentation
• 16 Invited lecture
• 10 Reviewer of Scientific Journal
• 7 Position of trust in an academic community
• 22 More
  • 6 Regular membership of a society or network
  • 4 Pre-examination of dissertation or acting as opponent to doctoral students
  • 4 Supervisor of licentiate candidate in medicine
  • 2 Supervisor of doctoral candidate
  • 2 Supervisor of licentiate candidate
  • 2 Position of trust in a funding organization
  • 1 Statement of assessment of docentship
  • 1 Supervisor of master student

Activities per year

Search results

• Adiponectin as a catabolic factor in OA. Adiponectin correlates with circulating COMP and MMP-3, and increases production of MMP-3, nitric oxide and IL-6 in human OA cartilage

  Katriina Vuolteenaho (Contributor), Eeva Moilanen (Contributor) & Riina Nieminen (Contributor)

  25 Mar 2011

  Activity: Talk or presentation › Conference presentation

• Proinflammatory and catabolic role of adipokines leptin and adiponectin in arthritis

  Anna Koskinen (Contributor), Eeva Moilanen (Contributor), Riina Nieminen (Contributor) & Katriina Vuolteenaho (Contributor)

  25 Mar 2011

  Activity: Talk or presentation › Conference presentation

• Proinflammatory and catabolic role of adipokines leptin and adiponectin in arthritis

  Anna Koskinen (Contributor), Eeva Moilanen (Contributor), Riina Nieminen (Contributor) & Katriina Vuolteenaho (Contributor)

  10 Feb 2011

  Activity: Talk or presentation › Conference presentation

• High leptin concentrations and low SOCS-3 expression are associated with increased MMP levels in obese osteoarthritis patients

  Katriina Vuolteenaho (Speaker), Anna Koskinen (Speaker), Eeva Moilanen (Speaker) & Riina Nieminen (Speaker)

  28 Jan 2011

  Activity: Talk or presentation › Conference presentation

• Plasma adiponectin is associated with radiographic knee osteoarthritis, and cartilage adiponectin production correlates with nitric oxide, IL-6 and MMP-3

  A Koskinen (Speaker), K Vuolteenaho (Speaker), S Juslin (Speaker), R Nieminen (Speaker), T Moilanen (Speaker) & E Moilanen (Speaker)

  28 Jan 2011

  Activity: Talk or presentation › Conference presentation

• Proinflammatory and catabolic role of leptin in osteoarthritis. Correlation with IL-6, MMP-1 and MMP-3 in synovial fluid and effects in human OA cartilage

  Anna Koskinen (Speaker), Eeva Moilanen (Speaker), Riina Nieminen (Speaker) & Katriina Vuolteenaho (Speaker)

  24 Sep 2010

  Activity: Talk or presentation › Conference presentation

• Leptin as a catabolic factor in osteoarthritis. Correlation with MMP-1 and MMP-3 in synovial fluid and effects on MMP production in human OA cartilage

  Anna Koskinen (Contributor), Eeva Moilanen (Contributor), Riina Nieminen (Contributor) & Katriina Vuolteenaho (Contributor)

  30 Aug 2010

  Activity: Talk or presentation › Conference presentation

• Predictive value of pretreatment adipocytokine levels for remission rates in early RA treated with DMARDs and infliximab

  Katriina Vuolteenaho (Contributor) & Riina Nieminen (Contributor)

  17 Jul 2010

  Activity: Talk or presentation › Conference presentation

• Proinflammatory and catabolic role of adipokines leptin and adiponectin in arthritis

  Katriina Vuolteenaho (Contributor), Anna Koskinen (Contributor), Eeva Moilanen (Contributor) & Riina Nieminen (Contributor)

  17 Jul 2010

  Activity: Talk or presentation › Conference presentation

• Catabolic role of leptin in osteoarthritis. Correlation with MMP-1 and MMP-3 in synovial fluid from OA patients and effects on human OA cartilage

  Anna Koskinen (Contributor), Eeva Moilanen (Contributor), Riina Nieminen (Contributor) & Katriina Vuolteenaho (Contributor)

  25 Mar 2010

  Activity: Talk or presentation › Conference presentation

• Adiponectin as a catabolic factor in OA correlation to OA biomarkers comp and MMP-3, and effects on no, MMP-3 and IL-6 production in human OA cartilage

  S Juslin (Speaker), K Vuolteenaho (Speaker), R Nieminen (Speaker), T Moilanen (Speaker) & E Moilanen (Speaker)

  28 Jan 2010

  Activity: Talk or presentation › Conference presentation

• Destructive role of leptin in osteoarthritis Correlation with MMP-1 and MMP-3 in synovial fluid from OA patients and effects in human OA cartilage

  Anna Koskinen (Speaker), Eeva Moilanen (Speaker), Riina Nieminen (Speaker) & Katriina Vuolteenaho (Speaker)

  28 Jan 2010

  Activity: Talk or presentation › Conference presentation

• Resistin is linked to inflammation and metabolic syndrome in women with inflammatory arthritis

  P Kontunen (Speaker), K Vuolteenaho (Speaker), R Nieminen (Speaker), H Kautiainen (Speaker), M Kauppi (Speaker), M Hakala (Speaker) & E Moilanen (Speaker)

  28 Jan 2010

  Activity: Talk or presentation › Conference presentation

• Adiponectin as a detrimental factor in OA. Correlation with biomarkers of OA, COMP and MMP-3 in male OA patients and effects on NO, MMP-3 and IL6 production in human OA cartilage

  Katriina Vuolteenaho (Contributor), Eeva Moilanen (Contributor) & Riina Nieminen (Contributor)

  20 Jan 2010

  Activity: Talk or presentation › Conference presentation

• Correlation with MMP and MMP3 in synovial fluid from OA patients and effects in human OA cartilage

  Anna Koskinen (Contributor), Eeva Moilanen (Contributor), Riina Nieminen (Contributor) & Katriina Vuolteenaho (Contributor)

  20 Jan 2010

  Activity: Talk or presentation › Conference presentation

• Resistin is linked to inflammation and metabolic syndrome in women with inflammatory arthritis

  P Kontunen (Contributor), K Vuolteenaho (Contributor), R Nieminen (Contributor), H Kautiainen (Contributor), M Kauppi (Contributor), M Hakala (Contributor) & E Moilanen (Contributor)

  20 Jan 2010

  Activity: Talk or presentation › Conference presentation

• Adiponectin as a catabolic factor in OA. Adiponectin correlates with circulating COMP and MMP-3, and increases production of MMP-3, nitric oxide and IL-6 in human OA cartilage

  Katriina Vuolteenaho (Contributor), Eeva Moilanen (Contributor) & Riina Nieminen (Contributor)

  11 Sep 2009

  Activity: Talk or presentation › Conference presentation

• Infliximab treatment in patients with rheumatoid arthritis and spondylarthropathies two years drug survival

  Tiina Levälampi (Contributor), Eeva Moilanen (Contributor) & Katriina Vuolteenaho (Contributor)

  7 Jul 2009

  Activity: Talk or presentation › Conference presentation

• Infliximab treatment in patients with rheumatoid arthritis and spondylarthropathies two years drug survival

  Tiina Levälampi (Contributor), Eeva Moilanen (Contributor) & Katriina Vuolteenaho (Contributor)

  20 Mar 2009

  Activity: Talk or presentation › Conference presentation

• Pretreatment levels of adipokines adipsin and leptin are associated with remission rates in early RA (NEO-RaCo study)

  Eeva Moilanen (Contributor), Tiina Levälampi (Contributor), Riina Nieminen (Contributor) & Katriina Vuolteenaho (Contributor)

  20 Mar 2009

  Activity: Talk or presentation › Conference presentation

• Leptin enhances MMP-1, MMP-3 and MMP-13 production in human OA cartilage

  K Vuolteenaho (Contributor), A Koskinen (Contributor), M Kukkonen (Contributor), R Nieminen (Contributor), T Moilanen (Contributor) & E Moilanen (Contributor)

  20 Mar 2009

  Activity: Talk or presentation › Conference presentation

• Infliximab treatment in RA and SpA. Drug survival and reasons for discontinuation during two years follow-up

  Tiina Levälampi (Contributor), Eeva Moilanen (Contributor) & Katriina Vuolteenaho (Contributor)

  29 Jan 2009

  Activity: Talk or presentation › Conference presentation

• Pretreatment levels of adipokines adipsin and leptin are associated with remission rates in early RA (NEO-RaCo study)

  Eeva Moilanen (Contributor), Tiina Levälampi (Contributor), Riina Nieminen (Contributor) & Katriina Vuolteenaho (Contributor)

  29 Jan 2009

  Activity: Talk or presentation › Conference presentation

• Leptin enhances MMP-1, MMP-3 and MMP-13 production in human osteoarthritic cartilage

  A Koskinen (Speaker), K Vuolteenaho (Speaker), M Kukkonen (Speaker), R Nieminen (Speaker), T Moilanen (Speaker) & E Moilanen (Speaker)

  29 Jan 2009

  Activity: Talk or presentation › Conference presentation

• Leptin enhances MMP-1, MMP-3 and MMP-13 production in human osteoarthritic cartilage

  Anna Koskinen (Speaker), Meiju Kukkonen (Speaker), Eeva Moilanen (Speaker), Riina Nieminen (Speaker) & Katriina Vuolteenaho (Speaker)

  23 Jan 2009

  Activity: Talk or presentation › Conference presentation

• Etanercept and adalimumab treatment in patients with RA and SpA in clinical practice: adverse events and other reasons leading to discotinuation of the treatment

  T Kylliäinen (Contributor), M Korpela (Contributor), K Vuolteenaho (Contributor) & E Moilanen (Contributor)

  23 Jan 2009

  Activity: Talk or presentation › Conference presentation

• Increased adipsin and low leptin levels are associated with higher remission rates in early RA patients treated with a combination of DMARDs (NEO-RACo study)

  Eeva Moilanen (Contributor), Tiina Levälampi (Contributor), Riina Nieminen (Contributor) & Katriina Vuolteenaho (Contributor)

  24 Oct 2008

  Activity: Talk or presentation › Conference presentation

• Leptin enhances MMP-1, MMP-3 and MMP-13 production in human OA cartilage

  Katriina Vuolteenaho (Contributor), Anna Koskinen (Contributor), Eeva Moilanen (Contributor) & Riina Nieminen (Contributor)

  18 Sep 2008

  Activity: Talk or presentation › Conference presentation

• Adipokines, interleukin-6 and metabolic syndrome in patients with inflammatory arthritis

  K Vuolteenaho (Contributor), R Nieminen (Contributor), H Kautiainen (Contributor), M Hakala (Contributor) & E Moilanen (Contributor)

  24 Jun 2008

  Activity: Talk or presentation › Conference presentation

• Possible role of adipocytokines in the pathogenesis of multiple sclerosis: A Finnish co-twin study

  A Hietaharju (Contributor), H Kuusisto (Contributor), R Nieminen (Contributor), K Vuolteenaho (Contributor), I Elovaara (Contributor) & E Moilanen (Contributor)

  12 Apr 2008

  Activity: Talk or presentation › Conference presentation

• Leptin induces detrimental changes in human OA cartilage. Effects on NO, PGE2, IL-6 and IL-8 production

  K Vuolteenaho (Contributor), A Koskinen (Contributor), M Kukkonen (Contributor), R Nieminen (Contributor), T Moilanen (Contributor) & E Moilanen (Contributor)

  13 Mar 2008

  Activity: Talk or presentation › Conference presentation

• Etanercept and adalimumab in patients with RA and SpA in clinical practice: adverse events and other reasons leading to discontinuation of the treatment

  T Läkinenpi (Contributor), M Korpela (Contributor), K Vuolteenaho (Contributor) & E Moilanen (Contributor)

  13 Mar 2008

  Activity: Talk or presentation › Conference presentation

• Etanercept and adalimumab treatment in patients with rheumatoid arthritis and spondyloarthropathies in clinical practice: adverse events and other reasons leading to discontinuation of the treatment

  Tiina Levälampi (Contributor) & Katriina Vuolteenaho (Contributor)

  31 Jan 2008

  Activity: Talk or presentation › Conference presentation

• Leptin induces IL-6 and IL-8 production in human OA cartilage in a NO-dependent manner

  Anna Koskinen (Contributor), Meiju Kukkonen (Contributor), Eeva Moilanen (Contributor), Riina Nieminen (Contributor) & Katriina Vuolteenaho (Contributor)

  30 Jan 2008

  Activity: Talk or presentation › Conference presentation

• Leptin induces detrimental changes in human OA cartilage. Effects on nitric oxide, PGE2, IL-6 and IL-8 production

  K Vuolteenaho (Contributor), A Koskinen (Contributor), M Kukkonen (Contributor), R Nieminen (Contributor), T Moilanen (Contributor) & E Moilanen (Contributor)

  6 Dec 2007

  Activity: Talk or presentation › Conference presentation

• Effects of iNOS inhibitor 1400W on inflammatory mediators in OA cartilage detected by antibody microarray

  Katriina Vuolteenaho (Speaker)

  19 Oct 2006

  Activity: Talk or presentation › Conference presentation

• Effects of iNOS inhibitor 1400W on inflammatory mediators in OA cartilage detected by antibody microarray

  Katriina Vuolteenaho (Speaker)

  2 Jul 2006

  Activity: Talk or presentation › Conference presentation

• The effects of nitric oxide on mediators of cartilage metabolism in human OA cartilage detected by antibody microarray

  Katriina Vuolteenaho (Speaker)

  23 Mar 2006

  Activity: Talk or presentation › Conference presentation

• The effects of nitric oxide on mediators of cartilage metabolism in human OA cartilage detected by antibody microarray

  Katriina Vuolteenaho (Speaker)

  8 Dec 2005

  Activity: Talk or presentation › Conference presentation

• TGF suppresses nitric oxide production in IL-1 treated chondrocytes by enhancing iNOS protein degradation

  Katriina Vuolteenaho (Speaker)

  17 Mar 2005

  Activity: Talk or presentation › Conference presentation

• Transforming growth factor (TGF) suppresses nitric oxide (NO) production in interleukin-1 (IL-1) treated chondrocytes by enhancing degradation of the inducible nitric oxide synthase (iNOS) protein

  Katriina Vuolteenaho (Speaker)

  20 Jan 2005

  Activity: Talk or presentation › Conference presentation

• Transforming growth factor suppresses nitric oxide production in murine H4 chondrocytes by enhancing degradation of inducible nitric oxide synthase protein

  Katriina Vuolteenaho (Speaker)

  2 Dec 2004

  Activity: Talk or presentation › Conference presentation

• Osteoarthritic changes and iNOS expression in experimental osteoarthritis model induced by cruciate ligament transsection in mouse knee

  Katriina Vuolteenaho (Speaker)

  18 Mar 2004

  Activity: Talk or presentation › Conference presentation

• Osteoarthritic changes and iNOS expression in experimental osteoarthritis model induced by cruciate ligament transsection in mouse knee

  Katriina Vuolteenaho (Speaker)

  12 Oct 2003

  Activity: Talk or presentation › Conference presentation

• Endogenous Cytokine Antagonists Regulate Nitric Oxide Production in Osteoarthritic Cartilage

  Katriina Vuolteenaho (Speaker)

  20 Mar 2003

  Activity: Talk or presentation › Conference presentation

• Role of endogenous cytokine antagonists in the regulation of nitric oxide production in osteoarthritic cartilage

  Katriina Vuolteenaho (Speaker)

  30 Jan 2003

  Activity: Talk or presentation › Conference presentation

• Endogenous Cytokine Antagonists Regulate Nitric Oxide Production in Osteoarthritic Cartilage

  Katriina Vuolteenaho (Speaker)

  22 Sep 2002

  Activity: Talk or presentation › Conference presentation

• Role of endogenous IL-1 inhibitors in the Regulation of nitric oxide production in osteoarthritic and rheumatoid cartilage

  Katriina Vuolteenaho (Speaker)

  16 Jun 2002

  Activity: Talk or presentation › Conference presentation

• Role of endogenous IL-1 inhibitors in the Regulation of nitric oxide production in osteoarthritic and rheumatoid cartilage

  Katriina Vuolteenaho (Speaker)

  21 Mar 2002

  Activity: Talk or presentation › Conference presentation

• Regulation of iNOS expression in osteoarthritic and rheumatoid cartilage

  Katriina Vuolteenaho (Speaker)

  11 Nov 2001

  Activity: Talk or presentation › Conference presentation